You are here

  • Home
  • Archive
  • Volume 77, Issue 4
  • Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial

Article info

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial
Free

Authors

  • Merel J l’Ami Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Reade, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Charlotte LM Krieckaert Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Reade, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Michael T Nurmohamed Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Reade, Amsterdam, Netherlands Rheumatology, Amsterdam Rheumatology and Immunology Center, Location VU University Medical Center, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Ronald F van Vollenhoven Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Reade, Amsterdam, Netherlands Rheumatology, Amsterdam Rheumatology and Immunology Center, Location VU University Medical Center, Amsterdam, Netherlands Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Amsterdam Medical Center, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Theo Rispens Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Maarten Boers Rheumatology, Amsterdam Rheumatology and Immunology Center, Location VU University Medical Center, Amsterdam, Netherlands Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Gerrit Jan Wolbink Rheumatology, Amsterdam Rheumatology and Immunology Center, Location Reade, Amsterdam, Netherlands Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Merel J l’Ami, Amsterdam Rheumatology and Immunology Center, Amsterdam 1056 AB, The Netherlands; m.lami{at}reade.nl
View Full Text

Citation

l’Ami MJ, Krieckaert CL, Nurmohamed MT, et al
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial
Annals of the Rheumatic Diseases 2018;77:484-487.

Publication history

  • Received May 12, 2017
  • Revised July 13, 2017
  • Accepted September 8, 2017
  • First published September 22, 2017.
Online issue publication 
March 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.